IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against IsoRay, Inc. And Advises Sharehol...
July 03 2015 - 8:19PM
Business Wire
Goldberg Law PC (www.Goldberglawpc.com) announces that a class
action lawsuit has been filed in the United States District Court
for the Eastern District of Washington against IsoRay, Inc.
(“IsoRay” or the “Company”) (NYSE: ISR), for alleged violations of
the federal securities laws. Investors who purchased or otherwise
acquired shares between May 20, 2015 and May 21, 2015 inclusive
(the “Class Period”), have until July 21, 2015 to serve as lead
plaintiff in the class action.
If you are a shareholder who suffered a loss during the Class
Period, we advise you to contact Michael Goldberg or Brian Schall,
of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del
Rey, CA 90292, at 800-977-7401, to discuss your rights without cost
to you. You can also reach us through the firm’s website at
http://www.Goldberglawpc.com, or by email at
info@goldberglawpc.com.
The class in this case has not yet been certified, and until
certification occurs, you are not represented by an attorney. If
you choose to take no action, you can remain an absent class
member.
IsoRay manufactures isotope-based medical products for the
treatment of cancer and other malignant diseases. The Company
produces Proxcelan Cesium-131 brachytherapy seeds for the treatment
of various cancers. According to the complaint, on May 20, 2015,
the Company issued a press release touting the publication of the
first major peer reviewed study of Cesium-131 seeds for the
treatment of non-small cell lung cancers. However, on May 21, 2015,
TheStreet.com published an article claiming that IsoRay selectively
edited findings from the study, making the product appear better
than it was. The author of the article, Adam Feuerstein, stated
that he did not consider the results of the study to be
“outstanding.” As a result of this news, shares of IsoRay fell over
35% on May 21, 2015, to close at $2.02 per share.
If you have any questions concerning your legal rights in this
case, please immediately contact Goldberg Law PC at 800-977-7401,
or visit our website at http://www.Goldberglawpc.com, or email us
at info@goldberglawpc.com.
Goldberg Law PC represents shareholders around the world and
specializes in securities class actions and shareholder rights
litigation.
This press release may be considered Attorney Advertising in
some jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150703005342/en/
Goldberg Law PC, Los AngelesMichael Goldberg, Esq.,
800-977-7401Brian Schall, Esq.,
800-977-7401info@goldberglawpc.comhttp://www.Goldberglawpc.comhttps://twitter.com/goldberglawpchttps://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts